Sotera Health CO DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Sotera Health Company has announced its 2026 Annual Meeting of Stockholders, scheduled for May 21, 2026, to elect directors, approve executive compensation, and ratify auditor appointment.
NASDAQ
DEFA14A: Sotera Health Company Updates Proxy Statement Regarding Board and Committee Meeting Attendance
Sotera Health Company issues a supplement to its definitive proxy statement, clarifying director attendance at board and committee meetings and the 2024 annual stockholder meeting.
NASDAQ
Sotera Health Company announces its 2025 Annual Meeting of Stockholders to be held on May 21, 2025, with voting open until May 20, 2025.
NASDAQ
Sotera Health sets date for its 2025 Annual Meeting of Stockholders to be held virtually on May 21, 2025, with proposals including director elections and executive compensation approval.
NASDAQ
Sotera Health Company released a supplement to its proxy statement to correct errors in board diversity graphics and voting standards for the upcoming annual meeting.
NASDAQ
Sotera Health Company's upcoming annual meeting on May 23, 2024, will include voting on director elections, executive compensation, auditor ratification, and an amendment to the company's certificate of incorporation.
NASDAQ
Sotera Health Company announces its 2024 Annual Meeting of Shareholders to be held virtually on May 23, 2024, featuring proposals for director elections, executive compensation approval, auditor ratification, and an officer exculpation amendment.